Literature DB >> 21835484

Association of cognitive dysfunction with hippocampal atrophy in elderly Japanese people with type 2 diabetes.

Kumi Hayashi1, Soichi Kurioka, Toru Yamaguchi, Miwa Morita, Ippei Kanazawa, Hirofumi Takase, Akihiko Wada, Hajime Kitagaki, Atsushi Nagai, Hirokazu Bokura, Shuhei Yamaguchi, Toshitsugu Sugimoto.   

Abstract

This study aimed to examine the associations of cognitive function with hippocampal and whole brain atrophies, age, education, and diabetes-related parameters in patients with type 2 diabetes. Sixty-one patients over 65 years of age with type 2 diabetes and 53 age- and sex-matched non-diabetic controls were enrolled. Hippocampal and whole brain atrophies were assessed by quantifying hippocampal and brain volumes by brain magnetic resonance imaging. Cognitive function was evaluated by Mini-Mental State Examination (MMSE) and the Revised Hasegawa Dementia Scale (HDS-R). Compared with the non-diabetic group, patients with type 2 diabetes showed significant increases in hippocampal and whole brain atrophies. The MMSE and HDS-R scores in type 2 diabetic patients showed significant negative correlations with age and significant positive correlations with years of education. These scores were also significantly negatively correlated with hippocampal atrophy, but not whole brain atrophy. Hippocampal atrophy in diabetic patients did not, however, correlate with age, years of education, or diabetes-related parameters. We showed hippocampal and whole brain atrophies to be more frequent in elderly patients with type 2 diabetes than in non-diabetic controls. Their cognitive functions were significantly and negatively associated with hippocampal atrophy.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21835484     DOI: 10.1016/j.diabres.2011.07.002

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  24 in total

1.  Brain functional networks: correlation analysis with clinical indexes in patients with diabetic retinopathy.

Authors:  Hui Dai; Yu Zhang; Lillian Lai; Su Hu; Ximing Wang; Yonggang Li; Chunhong Hu; Hailin Shen
Journal:  Neuroradiology       Date:  2017-08-22       Impact factor: 2.804

Review 2.  Shared neurobiological pathways between type 2 diabetes and depressive symptoms: a review of morphological and neurocognitive findings.

Authors:  Todd Doyle; Angelos Halaris; Murali Rao
Journal:  Curr Diab Rep       Date:  2014-12       Impact factor: 4.810

Review 3.  Modifiable factors that alter the size of the hippocampus with ageing.

Authors:  Majid Fotuhi; David Do; Clifford Jack
Journal:  Nat Rev Neurol       Date:  2012-03-13       Impact factor: 42.937

4.  Brain structural alterations detected by an automatic quantified tool as an indicator for MCI diagnosing in type 2 diabetes mellitus patients: A magnetic resonance imaging study.

Authors:  Jing Gu; Siyuan Cui; Huihui Qi; Jing Li; Wenjuan Wu; Silun Wang; Jianming Ni; Zengli Miao
Journal:  Heliyon       Date:  2022-05-12

5.  Occurrence of mild cognitive impairment with hyperinsulinaemia in Africans with advanced type 2 diabetes mellitus.

Authors:  J Bashir; I U Yarube
Journal:  IBRO Neurosci Rep       Date:  2022-02-17

6.  Effect of leukocyte telomere length on total and regional brain volumes in a large population-based cohort.

Authors:  Kevin S King; Julia Kozlitina; Roger N Rosenberg; Ronald M Peshock; Roderick W McColl; Christine K Garcia
Journal:  JAMA Neurol       Date:  2014-10       Impact factor: 18.302

7.  Insulin resistance, diabetes mellitus, and brain structure in bipolar disorders.

Authors:  Tomas Hajek; Cynthia Calkin; Ryan Blagdon; Claire Slaney; Rudolf Uher; Martin Alda
Journal:  Neuropsychopharmacology       Date:  2014-06-19       Impact factor: 7.853

8.  Identification of predictors for mini-mental state examination and revised Hasegawa's Dementia Scale scores using MR-based brain morphometry.

Authors:  Koji Yamashita; Takahiro Kuwashiro; Kensuke Ishikawa; Kiyomi Furuya; Shino Harada; Seitaro Shin; Noriaki Wada; Chika Hirakawa; Yasushi Okada; Tomoyuki Noguchi
Journal:  Eur J Radiol Open       Date:  2021-05-24

9.  Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study.

Authors:  Kazuhiko Tsuruya; Hisako Yoshida; Naoki Haruyama; Kiichiro Fujisaki; Hideki Hirakata; Takanari Kitazono
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

10.  Brain atrophy in type 2 diabetes: regional distribution and influence on cognition.

Authors:  Chris Moran; Thanh G Phan; Jian Chen; Leigh Blizzard; Richard Beare; Alison Venn; Gerald Münch; Amanda G Wood; Josephine Forbes; Timothy M Greenaway; Susan Pearson; Velandai Srikanth
Journal:  Diabetes Care       Date:  2013-08-12       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.